Additional studies in an orthotopic MB49 bladder cancer model showcased significant tumor regression with NHS-IL12 associated with decreases in immunosuppressive tumor TGFβ levels, MDSCs and TAMs, while increasing M1-macrophages and CD4+ and CD8+ T cell responses (17, 36). The gene discussed is TGFB1; the disease is neoplasm.